Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF ‐ κB signaling pathways
Journal of Diabetes Investigation · 2026
DOI: 10.1111/jdi.70267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Reyhane Ghayour Vatanparast und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Oxidative Stress, NF-E2-Related Factor 2, NF-kappa B. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Diabetic nephropathy (DN) is a common and serious microvascular complication of diabetes mellitus, primarily driven by persistent hyperglycemia‐induced oxidative stress and chronic inflammation. Calebin A, a naturally occurring noncurcuminoid compound, has shown promising antioxidant and anti‐inflammatory effects in various disease models. This study aimed to evaluate the nephroprotective effects and underlying mechanisms of calebin A in an experimental model of DN.
Methods
DN was induced in C57BL/6 mice using streptozotocin (STZ). Diabetic mice were treated with calebin A, curcumin, or metformin for 6 weeks.
Results
Treatment with calebin A resulted in significant improvements in glycemic control, renal function, oxidative stress, inflammation, fibrosis, and renal histopathological alterations. Calebin A reduced oxidative stress and inflammation by activating the Nrf2 pathway and downregulating the NF‐κB signaling pathway. Histological analyses supported these findings by demonstrating marked attenuation of STZ‐induced renal damage following calebin A administration.
Conclusion
These results highlight the multitargeted nephroprotective effects of calebin A in DN. Further long‐term and clinically oriented studies are warranted to validate these effects in chronic disease settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
- Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, Turkey.
- Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India.
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Prashant Kesharwani, Amirhossein Sahebkar
Zitieren
APA
Vatanparast, R. G., Aliyari, M., Yazdi, M. P., Alidadi, S., Sokhanvar, M. R., Karav, S., Kesharwani, P., Hosseini, H., & Sahebkar, A. (2026). Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF ‐ κB signaling pathways. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70267
Vancouver
Vatanparast RG, Aliyari M, Yazdi MP, Alidadi S, Sokhanvar MR, Karav S, et al. Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF ‐ κB signaling pathways. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70267
BibTeX
@article{Vatanparast2026,
author = {Vatanparast, Reyhane Ghayour and Aliyari, Mahdieh and Yazdi, Mahla Palizkaran and Alidadi, Soodeh and Sokhanvar, Mohammad Reza and Karav, Sercan and Kesharwani, Prashant and Hosseini, Hossein and Sahebkar, Amirhossein},
title = {Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF ‐ κB signaling pathways},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70267}
}
EUVIMED